Physiocrine-based Medicines

Physiocrines™ offer a completely new set of physiologic extracellular pathways for developing novel therapeutics.  These natural human proteins function in normal and pathologic settings, yet act via mechanisms that are differentiated and potentially superior from other therapeutic approaches.

As either therapeutic proteins or as targets for antibodies, Physiocrines™ have the potential to address a wide range of diseases, including high unmet patient needs in blood, immune, and metabolic disorders.  aTyr is currently developing several Physiocrine products in these therapeutic areas.